SFX by Ex Libris Inc.

Title:	An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Source:	Nature [0028-0836] Opitz, Christiane yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Veldhoen, M. "The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins." Nature 453.7191 (2008): 106-9.
description	2.	Boudakov, I. "An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4࠽ T regulatory cells." The journal of immunology 180.9 (2008): 5946-55.
description	3.	Esser, C. "The aryl hydrocarbon receptor in immunity." Trends in immunology 30.9 (2009): 447-54.
description	4.	Serbecic, Lahdou I. "Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells." Molecular vision 15.139-40 (2009): 1312-1324.
description	5.	Tadaatsu, S. "Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression." Genes to cells 13.2 (2008): 131-44.
description	6.	Quintana, Howard L L. "Control of T-reg and TH17 cell differentiation by the aryl hydrocarbon receptor." Nature 453.7191 (2008): 65-71.
description	7.	Ishii, M. "Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis." Nature 458.7237 (2009): 524-8.
description	8.	Veldhoen, M. "Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells." The Journal of experimental medicine 206.1 (2009): 43-9.
description	9.	Ohdo, S. "Time-dependent interaction between differentiated embryo chondrocyte-2 and CCAAT/enhancer-binding protein α underlies the circadian expression of CYP2D6 in serum-shocked HepG2 cells." Molecular pharmacology 81.5 (2012): 739-747.
description	10.	Kaira, K. "LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer." American journal of translational research 3.5 (2011): 468-478.
description	11.	Tandon, A. "Gene therapy in the cornea: 2005--present." Progress in Retinal and Eye Research 31.1 (2012): 43-64.
description	12.	Zhu, J. "Increased expression of aryl hydrocarbon receptor and interleukin 22 in patients with allergic asthma." Asian Pacific Journal of Allergy and Immunology (2011): 266-272.
description	13.	Stockinger, B. "Beyond toxicity: aryl hydrocarbon receptor-mediated functions in the immune system." Journal of biology 8.7 (2009): 61-61.
description	14.	Jungraithmayr, W. "CD26/Dipeptidylpeptidase IV and vasoactive intestinal peptide in mouse lung transplant ischemia/reperfusion injury." Transplantationsmedizin 21.SUPPL. 2 (2009): 28-29.
description	15.	Tato, Cristina M. "Innate IL-17-producing cells: the sentinels of the immune system." Nature Reviews. Immunology 10.7 (2010): 479-489.
description	16.	Bock, K. "The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver." Biological Chemistry 390.12 (2009): 1225-1235.
description	17.	Cho, Jiyun J. "Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells." Cell biology international 31.10 (2007): 1225-30.
description	18.	Taylor, Kevin L L. "Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression." Microvascular Research 64.3 (2002): 372-83.
description	19.	Jeffrey F, B. "Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter." The FASEB journal 22.1 (2008): 19-29.
description	20.	FERNANDEZSALGUERO, P. "IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR." Science 268.5211 (1995): 722-726.